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Abstract: Background: To inform interventions to improve antimicrobial use in urinary tract
infections (UTIs) and contribute to a reduction in Escherichia coli bloodstream infection, we explored
factors influencing the diagnosis and management of UTIs in primary care. Design: Semi-structured
focus groups informed by the Theoretical Domains Framework. Setting: General practice (GP)
surgeries in two English clinical commissioning groups (CCGs), June 2017 to March 2018. Participants:
A total of 57 GP staff within 8 focus groups. Results: Staff were very aware of common UTI symptoms
and nitrofurantoin as first-line treatment, but some were less aware about when to send a urine
culture, second-line and non-antibiotic management, and did not probe for signs and symptoms to
specifically exclude vaginal causes or pyelonephritis before prescribing. Many consultations were
undertaken over the phone, many by nurse practitioners, and followed established protocols that
often included urine dipsticks and receptionists. Patient expectations increased use of urine dipsticks,
and immediate and 5 days courses of antibiotics. Management decisions were also influenced by
patient co-morbidities. No participants had undertaken recent UTI audits. Patient discussions
around antibiotic resistance and back-up antibiotics were uncommon compared to consultations for
respiratory infections. Conclusions: Knowledge and skill gaps could be addressed with education
and clear, accessible, UTI diagnostic and management guidance and protocols that are also appropriate
for phone consultations. Public antibiotic campaigns and patient-facing information should cover
UTIs, non-pharmaceutical recommendations for “self-care”, prevention and rationale for 3 days
antibiotic courses. Practices should be encouraged to audit UTI management.
Keywords: antibiotic prescribing; antimicrobial resistance; survey; questionnaire; knowledge;
expectations; antibiotics; delayed prescribing; Escherichia coli bloodstream infection; EBSI; bloodstream
infection; BSI; pyelonephritis; behavioural science; general practice; diagnostic
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Strengths and limitations of this study:
(1) By purposively selecting CCGs with different sociodemographic characteristics and then inviting
surgeries to participate in a random order, we were able to reduce bias and get input from surgeries with
a range of antibiotic prescribing rates.
(2) We were able to speak with 57 staff members from 8 practices with various roles in the management
pathway. This allowed us to explore the behaviour of non-prescribers.
(3) General practices that were more overburdened or going through changes were more likely to decline to
participate, and their views may not have been captured.
(4) Using the Theoretical Domains Framework to develop our focus group schedule allowed us to explore all
areas of behaviour and fed into intervention development.
(5) Nesting this piece of research within a project that included the development of UTI resources for all
ages, including a UTI flowchart and leaflet for older adults, could have biased discussion to focus more
on management in older adults (which is seen as more complex by clinicians) even when general
feedback was prompted for during the discussion.
1. Introduction
Escherichia coli is the main cause of bloodstream infection in the UK and is responsible for more than
one-third of bloodstream infection cases in England each year [1,2]. Yearly rates of E. coli bloodstream
infections (ECBSIs) increased by 12% between 2014 and 2018 (65.7/100,000 population in 2014 to
76.0/100,000 population in 2018) [3]. Modelling, using English mandatory surveillance data in 2017,
showed that if rising trends are not influenced, there will be a 5.1% year-on-year increase in incidence
of ECBSIs by 2020/21 [4]. This will be even higher for community onset cases (7.8%) [4].
Because most cases of ECBSI (51% of cases) are attributed to an underlying urological condition,
infections of the urogenital tract contribute the highest number of deaths when comparing 30
days all-cause mortality in people with ECBSI [2,5]. Independent risk factors for ECBSI related to
the urogenital tract include experiencing or having treatment for a UTI in the previous month, having
a short- or long-term urinary catheter, and being a woman [2,6–8].
We may be able to prevent and reduce ECBSIs if we effectively diagnose and manage community
acquired UTIs in adults [9]. Antimicrobial stewardship policies and interventions over the last decade
have focused on improving management of common infections presenting in primary care [10,11].
However, key challenges of inappropriate prescribing and diagnosis remain for UTI and overuse
has continued to drive antimicrobial resistance in Gram-negative organisms causing UTIs and
BSIs. One-fifth of antibiotic prescriptions between 2013 and 2015 in England were for UTI-related
conditions [12]. In 2014, English UTI antibiotic guidelines changed to suggest nitrofurantoin as first-line
treatment for lower UTI, and in 2016/17, a reduction in the trimethoprim:nitrofurantoin prescribing
ratio was included in the Quality Premium [13]. This has probably contributed to the significant
decreases in trimethoprim use (by 41% since 2014) and a decrease in E. coli-resistant trimethoprim
within UTI samples in England (35.1% to 31.2% between 2015 and 2018) [3]. However, we know
that these improvements have varied significantly between health authorities across England and
more needs to be done to support the universal use of national prescribing guidance [14]. Greater
trimethoprim prescribing (compared to nitrofurantoin) is associated with a higher incidence of BSI,
UTI-related trimethoprim-resistant E. coli BSI, and increased incidence of trimethoprim-resistant
bloodstream infection [9].
To help inform interventions to improve the management and diagnosis of UTIs within primary
care, the authors explored GP staff’s diagnosis and management of UTI in adults under 65 years.
This coincided with a planned review of the 2017 Public Health England (PHE) diagnosis of urinary
tract infections: quick reference tool for primary care [15]. Specific aims of this review included:
i. Determine the practices of primary health care staff when diagnosing and treating UTIs
in patients under 65 years in the primary health care setting,
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ii. identify where there are current barriers and facilitators to appropriate diagnosis and
treatment, and
iii. identify how these gaps may be addressed through resource development or other measures.
Although the aims of the review included the whole population of England, large parts of the focus
group discussions were focused on women under 65 years, and this is the focal group for the qualitative
findings highlighted in this paper.
2. Methods
We aimed to attain views from primary health care staff with a range of experience around
the diagnosis and management of UTI in England. Therefore, we purposively sampled in two areas
with different demographics/populations: Gloucestershire and Nottingham City (CCGs). These two
clinical commissioning groups (CCGs) were chosen as they provided different types of urban/rural,
socioeconomic and ethnic population breakdowns based on information from the 2011 UK national
census (Table 1) [16].
Table 1. Demographic and health equality indicators for Nottingham City and Gloucestershire clinical
commissioning groups (CCGs).
Indicators (2017/18) Nottingham City CCG Gloucestershire CCG English Level Statistic
Total Population Estimates—mid
2018 [17] 331,069 633,558 55,977,178
Healthy life expectancy at birth for
women in years 53.5 [18] 65.7 [19] 63.8 [18]
Life expectancy gap for women
in years 8.6 [18] 5.4 [20] 7.5 [18]
% of all people with a limiting
long-term illness 18.1 [18] 16.7 [19] 17.6 [18]
% of all people who are black and
ethnic minority (2011 census) [16] 34.7 4.6 14.6
Deprivation score 36.9 [18] 15.0 [19] 21.8 [19]
CCGs commission medical care for GP practices, deciding what services are needed for diverse
local populations, and ensuring that they are provided. Most people who reside in the UK have
access to primary care through a GP practice. Practices vary in their rates of urine submission to
local laboratories, and this may be associated with differing staff views on the management of UTI.
To account for this, practices in each CCG were stratified by higher, middle or lower rates of local
laboratory urine specimen submission. To try and reduce sampling bias and to avoid only enrolling
practices with an interest in UTIs, GP practices in each stratum were randomised and then approached
by letter and telephone in random order until one practice per strata in each region was recruited.
Invitation letters from PHE contained study information sheets and a consent form.
Each participant was offered a £20 high-street voucher incentive to participate. Response rates
were 25% (n = 16/4) and 24% (n = 17/4) in the Gloucestershire and Nottingham City CCGs, respectively.
Data was collected from June 2017 to March 2018 (Figure 1).
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Figure 1. Sample selection.
Focus group discussion schedules were developed by the research group, including 2
microbiologists, a patient, a psychologist, researchers an a GP, and were informed by the Theoretical
Domains Framework (TDF) (Table 2) [21]. Topic areas included primary care staff attitudes and
experiences of managing suspected and proven urinary tract infections, antimicrobial resistance and
antibiotics, and a discussion with staff about their thoughts and opinions on the diagnostic process
proposed in the draft UTI diagnostic flowchart. The focus group discussion schedule for the practices
was piloted, but there were no significant changes made following the pilot and findings from this
group are included in the results.
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Table 2. Interview discussion guide (summarized) and corresponding TDF domains.
Sections within the Interview Schedule Main Domains Explored in the TDF
Section One: Current UTI Management
1. Normal process for diagnosing a UTI
in their surgery. Knowledge/skills/social professional role and identity
2. Biggest challenges faced when diagnosing
a UTI in their surgery?
Environmental context and resources/beliefs about
capabilities
3. Differences in diagnostic process when
assessing older and younger age groups. Knowledge/skills/beliefs about consequences
4. Determining the need for antibiotics for
a suspected UTI and how easy it is to work out.
Memory, attention and decision making/beliefs about
consequences/social influence/beliefs about
capabilities
5. Determining if urine is collected or sent
for culture.
Memory, attention and decision making/social
influence
6. How instructions are given on how and when
staff or patients should collect a urine sample.
Behavioural regulation/social professional role and
identity
7. How a practice monitors and regulates
the diagnosis and management of UTIs
(including antibiotic use).
Environmental context and resources/reinforcement
8. Barriers to diagnosing suspected UTI
in different groups including the influence of
family and caregivers.
Environmental context and resources/social
influences/emotions
9. Discussing benefits vs risks of antibiotics
with patients. Skill/intentions/goals
10. Views/experiences of antibiotic resistance
in relation to UTIs.
Memory, attention and decision making/beliefs about
consequences/behavioural regulation




12. Ways to reduce the number patients who are
prescribed antibiotics (role specific).
Optimism/social professional role and
identity/motivation/goals
Section Two: Ways we could reduce UTIs or
improve UTI management
1. Diagnostic or treatment guidance currently
used to manage patients with a suspected UTI.
Environmental context and resources/behavioural
regulation/reinforcement
2. Support/resources that would assist
in identification and diagnosing UTI. Skills/environmental context and resources
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Table 2. Cont.
Sections within the Interview Schedule Main Domains Explored in the TDF
Section Three: How a UTI resource might be used
to improve diagnosis and treatment (corresponds
with a step by step review of the previous or updated
UTI diagnostic resources)
1. Information in a reference tool that would help
with UTI prevention, diagnosis
and management.
Knowledge/memory, attention and decision
making/skills
2. Discuss the usefulness of this type of resource.
Environmental context and resources/memory,
attention and decision making/beliefs about
capabilities
3. Discuss the layout and wording used
in the diagnostic tool.
Knowledge/memory, attention and decision
making/skills
4. Discuss what would make a quick reference
tool like this more attractive or usable for
practice staff.
Environmental context and resources
5. Discuss challenges in using a resource like this
diagnostic tool. Beliefs about capabilities/reinforcement
Focus groups were facilitated and observed by trained qualitative researchers, held in general
practices, and lasted from 30 to 90 min. Discussions were audio-recorded, transcribed verbatim and
checked for accuracy by a member of the research team.
Data was analysed inductively by PHE researchers, LJ and RA, using QSR Nvivo 10 [22,23].
Themes were refined until redundant or infrequent codes were recoded. Ten percent of transcripts were
double coded by a second researcher (NG). Codes were discussed by the researchers, and a consensus
was reached. After this initial analysis, the results with representative participants’ quotes were
discussed by the research group and at an expert stakeholder workshop attended by GPs, nurses,
pharmacists, public representatives, microbiologists, and other medical professionals. The themes were
then considered within the TDF framework. After each focus group, GP staff’s opinions were used to
tentatively modify a UTI quick reference diagnostic tool for the next focus group. Quotes specific to
patients over the age of 65 years were coded apart from those from the discussion about general patients
and are presented elsewhere [24]. Though the general discussion did at times include discussion
around men and a children, most of the focus was on younger women presenting at the practice as this
was the focus of the UTI diagnostic tool.
Quotations from the transcripts are used in the results table to illustrate the most prominent TDF
domains (Table 3) and findings. The terms used to explain how many groups agreed on or discussed
an issue or finding in the results include “most”—meaning that 4 or more focus groups raised or
discussed the issue; or “some” meaning that 1 to 3 groups raised or discussed the issue.
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Table 3. Key findings and how they influenced the development of the UTI diagnostic tool for women under 65 years. (Results (Applied to the TDF Domains)).
Domain and Findings * Quote (F Stands for Female, M for Male, Int Stands for Interviewer and GPStands for General Practice) How the Findings Influenced the UTI Diagnostic Tool
Knowledge
Some general practice staff reported that they did not know about
pivmecillinam or fosfomycin as second-line treatment for acute
uncomplicated UTI.
“F1: I’ve never even heard of it before (pivmecillinam). What’s it called . . . ? F3:
Not seen it at all. M1: I’ve not seen that at all.” (GP 8)
The updated diagnostic tool:
• Links to latest national guidance on antimicrobial prescribing
for UTIs;
• Lists the main at-risk groups and other risk factors to consider for
antibiotic resistance, and
• Links to a UTI leaflet for women under 65 years that explains
evidenced-based prevention and self-care recommendations.
GP practices discussed frequent/recent use of antibiotics, long
duration/high doses of antibiotics, recurrent UTI, and positive lab
results as risk factors for antibiotic resistance.
“Certainly, the people coming back, recurrent UTIs . . . you sometimes think are
we actually missing something here are they having proper UTI, the dipstick
might show it but actually having an MSU with a proven UTI can help
in the long term, so that’s one group.” (GP 5)
Practice suggestions for prevention of UTI focused on hydration,
sachets/cranberry products, lemon barley water, and wiping front to
back.
“M1: Occasionally Cystopurin. F1: . . . the sachets. Especially if the dipstick’s
negative. M1: I’d even recommended sodium bicarbonate . . . F2: It used to be
barley water in my day . . . . F3: Basically just get as much fluid down you as you
can and flush it out.” (GP 6)
Some GP staff discussed conflicting information regarding the use of
cystitis sachets and cranberry products for prevention or treatment of
UTIs.
“Cranberry juice seems to have fallen out of fashion. The wording . . .
in the guidance now . . . is that cranberry juice is effective for some women,
but there is very limited research to back it up. the impression that we get is that
the reason why cranberry juice is working is because they’re drinking a lot of
fluid.” (GP 1)
Environmental context and resources
Some GP staff reported that phone consultations (sometimes with
dipstick results) are being used to assess and treat patients at risk for
a UTI.
“ . . . we ask them relevant questions, how long they’ve had the symptoms for, have
they tried any over the counter, what are their symptoms, whether it’s dysuria,
frequency, back pain, temperature, nausea, vomiting, that sort of thing,
and it depends on the answers . . . particularly at our surgery, if they’re under 65,
we just, they give them a prescription over the phone.” (GP 1) The updated diagnostic tool:
• Clearly outlines how to clinically assess someone with
suspected UTI;
• Includes prompts/considerations around differential diagnosis,
pyelonephritis, and sepsis;
• Clearly outlines the steps for clinical assessment of someone with
suspected UTI and when a urine dipstick test or culture is needed;
• Provides information on the sensitivity and specificity when
using urine dipsticks to diagnose a UTI for women under
65 years;
• Has been developed as an update to previous guidance;
• Links to latest national guidance on antimicrobial prescribing for
UTI management (developed since this study was conducted);
• Links to UTI leaflets and resources for women under 65 years that
explains evidenced-based prevention and
self-care recommendations.
Some groups reported that they would prescribe antibiotics over
the phone for a patient under the age of 65 with 2–3 urinary symptoms.
At the telephone consultation, some practice staff asked for a urine
sample to be brought in but others considered this as unnecessary.
“Int: how would you diagnose a suspected UTI over the phone versus in face to
face consultation? F1: Well just do the same but not examine them or dip it . . .
we tend to not ask for a sample unless there was something complicated about
them.” (GP 3)
Some practice staff reported that patients ‘drop and run’, leaving urine
samples at reception, often because they think they might have a UTI.
Clinicians then ring the patient for a clinical history.
“M1: . . . we do end up with patients just turning up and leaving urine samples
at the desk. Int: So what determines whether they get sent for culture? M1: Well,
well they get dipped but then we want to know a bit more of the clinical
information so . . . the nurses comes and says, I’ve checked this urine. We need
a bit more than that . . . I think commonly we’d just end up phoning the patient
and saying look . . . why have you dropped it off?” (GP 2)
Some GP staff feel that easy availability of urine samples influences
their decision to use urine dipsticks as part of the diagnostic process.
“ . . . think for the vast majority we would test . . . even in females under 65 who
. . . you certainly don’t need to send a culture for but if a urine is easily obtainable
we’d normally get one.” (GP 2)
Most GP staff followed 2017 PHE guidance for UTI diagnosis and
which focused on the key symptoms of dysuria, urgency and
frequency as symptoms and would not include findings from the most
recent literature.
“ . . . and I use the current guidance to decide whether to treat without dipping
the urine or to just go ahead and treat. And I think it’s if they have three
symptoms, that you don’t have to dip the urine and you just treat. If they’re under
65 and they’re a woman then I would tend to use that . . . .” (GP 2)
Most GP staff agreed that the exclusion of pyelonephritis and sepsis
needed to be included in tools that are developed to diagnose UTI.
“I think sepsis has to be first, doesn’t it? It’s the trump card, is it?” (GP 4)“ . . .
and obviously, you’ve got to think about sepsis now.” (GP 6)
Some GP staff expressed the need for more national guidance specific
to the management of UTIs.
“ . . . something on recurrent UTI would be really helpful because . . . some
guidance . . . just sort of says consider this, consider that . . . there’s a lot more
interpretation with recurrent UTI.” (GP 2)
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Table 3. Cont.
Domain and Findings * Quote (F Stands for Female, M for Male, Int Stands for Interviewer and GPStands for General Practice) How the Findings Influenced the UTI Diagnostic Tool
Some GP staff reported that lab specimen service pickups were not
frequent enough to allow culture results to inform treatment, which
leads to overcautious prescribing.
“ . . . I’m going to treat because I won’t get the result of this MSU, this is
a Thursday I’m not going to get it till Tuesday so we tend to treat.” (GP 7)
Some GP staff reported that they did not have the option of using
fosfomycin or pivmecillinam as second-line treatment.
“F1: But they didn’t actually have fosfomycin or pivmecillinam on the (sensitivity
reporting) list. M1: No they don’t have fosfomycin . . . .” (GP 2)
Most GP staff indicated that more information or education for
patients on UTI was needed, including a UTI leaflet and public health
information/campaign that covers the prevention and treatment of UTI
in line with national guidance.
“ . . . like with coughs and colds everyone knows now that they’re not going to get
an antibiotic necessarily, they’ve braced themselves for the bad news, haven’t they?
But with UTI they wee once and it stings and . . . they separate it and somehow
it doesn’t go under that hurt. It’s literally they’re right in, aren’t they, really
quickly.” (GP 8)
Role and professional identity
Some GP staff reported that receptionists in some surgeries ask
patients who ring up to bring urine samples into the surgery and
provide guidance on sample collection.
“The receptionists actually, if anybody rings up and says, I think I’ve got a UTI
they, they say can you, next time you go can you make sure you keep a clean
catch? So that we’ve already started a process of looking at having a . . . dip
if needs be.” (GP 2)
The updated diagnostic tool:
• Can be displayed in a surgery so that staff members can access it;
• Uses clear language that can be understood by different types of
health professionals;
• Outlines the steps for clinical assessment and when a urine
dipstick test/culture is needed;
• Provides information on the sensitivity and specificity of urine
dipsticks to diagnose a UTI for women under 65 years;
• Includes prompts/considerations around other diagnosis,
pyelonephritis, and sepsis;
• Links to national sepsis guidance;Includes information on when
to refer patients who have recurrent UTI or other
significant symptoms.
Some GP staff reported that nurses may be responsible for testing
urine samples left at reception and referring to clinicians if they are
concerned the patient has a UTI.
“ . . . often, they’ve already had a urine dipped by our nurses by the time that they
get to us . . . . If the other nurses see someone and they’re suspecting a UTI they’ll
. . . ask us to prescribe, but they’ll tell us what they’ve found, examination wise
and history. So run it by us.” (GP 2)
Some GP staff reported that nurse prescribers frequently see
uncomplicated cases of UTI independently.
“ . . . I (nurse prescriber) deal predominantly in the triage and assessment of acute
illnesses and UTIs being probably quite an awful lot of it and it’s part of a team
where we prescribe quite regularly for it following national guidelines.” (GP 8)
Some GP staff reported that general practitioners will deal with UTIs
but often focus on complicated cases or treatment failures.
“I tend to be seeing people who either they’ve got complicated features or they’ve
had treatment already, or there’s something else . . . . I do quite a bit of telephone
work, advice work.” (GP 1)
Skills
Some GP staff asked about vaginal discharge during a consultation,
and one group reported this was done after using a urine dipstick to
rule out a UTI.
“ . . . you ask for certain symptoms . . . if it sounds like a UTI and it seems like
a UTI on a dipstick you treat as such. It would only be if you weren’t sure, if you
needed to think about other symptoms then you would say have you got a vaginal
discharge.” (GP 7)
The updated diagnostic tool:
• Flags the need to assess for vaginal discharge early
in the diagnostic process;
• Suggests when to use urine dipsticks;
• States criteria for sending urine for culture;
• Links to a UTI leaflet for women under 65 years that provides
evidenced-based recommendations for self-care, prevention,
and safety netting.
Most groups said they would send a culture following treatment
failure or for a recurrent UTI but only some groups reported sending
a urine for culture if the dipstick was negative but the patient
symptomatic, if the patient was quite unwell, for male patients,
pregnant women and for children.
“ . . . I don’t use an age cut off. It’s more around their past history, for instance
if they’re pregnant or something. Or if their symptoms aren’t very clear cut,
or if they’re unwell or they’ve had recurrent then I will send off . . . . If it’s
a treatment failure or they come back and their symptoms aren’t fully cleared up,
second time round, then certainly we’d send it off at, on the second appointment if,
if needed, if they come back...” (GP 3)
Some groups indicated that they would not send a urine culture
if the dipstick was negative or if the symptoms clearly indicated
an uncomplicated UTI.
“With different things depending on the patient. So a pregnant or recurrent or,
we’re more likely to send a urine off. We don’t send them off if it’s
an uncomplicated UTI with typical symptoms.” (GP 3)
Most GP staff reported discussing non-medical advice with their
patients. This was in the context of self-care for mild symptoms
(especially with a negative dipstick), or preventing UTI recurrence.
“Yeah, but if they’ve got relatively mild symptoms or few symptoms you can let
them carry on flushing it out . . . ” (GP 2)
Some GP staff reported differences of opinion on interpretation/use of
urine dipstick; especially when symptoms do not match urine dipstick
results which challenge UTI diagnosis.
“ . . . people with recurrent symptoms . . . doesn’t always match up the symptoms
that they have with the findings in their urine and possibly their expectation for
treatment.” (GP 2)
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Table 3. Cont.
Domain and Findings * Quote (F Stands for Female, M for Male, Int Stands for Interviewer and GPStands for General Practice) How the Findings Influenced the UTI Diagnostic Tool
Social Influence
Some GP staff feel that patient expectation influences their decision to
use urine dipsticks as part of the diagnostic process.
“ . . . if they’re young, fit, well, uncomplicated and got typical symptoms,
technically you don’t need to do a dipstick. But you often still do it because
the patients have that expectation because they want to be told this is definitely
a urine infection. If you just say, you’ve got typical symptoms here are antibiotics,
they still feel as though they want to be told this is an infection, so they will ask for
it to be dipped or expect it to be dipped.” (GP 3)
The updated diagnostic tool:
• Links to a UTI leaflet for women under 65 years that provides
support to a clinician when discussing with a patient about:
o When a dipstick result should be used to diagnose a UTI;
o What a delayed prescription is and when to use it;
o Safety netting advice;
o Evidenced-based self-care and prevention advice for UTIs,
including over-the-counter products.
Some practices generally felt that patients did not understand that
a UTI can clear on its own safely and expected treatment and believe
that patients react differently to a no antibiotic decision with
respiratory infections due to more consistent messaging/campaigns
in this area.
“Almost never, usually, if it’s for something like a sore throat or what have you,
then . . . they’re getting more receptive, because it’s been a consistent message that
they’re not going to get antibiotics unless X, Y, Z, but in urinary tract infections
almost never, they just want them.” (GP 4)
Some practices talked about how patients might obtain cystitis sachets
from the community pharmacy and will only come for a consultation
if symptoms don’t improve.
“ . . . because we do get patients who have been to the pharmacist and I don’t see
the ones who don’t come back, but I do see the ones who do, and . . . after week later
they’re now going their urine is painful and they need antibiotics . . . .” (GP 5)
Beliefs about consequences
Some GP practices indicated that concern about issues like sepsis
causes them to be overly cautious when diagnosing and treating UTIs.
“ . . . it’s confidence around knowing . . . what happens if we don’t treat it, there is
that risk or pyelonephritis and becoming septic . . . because of this lack of
confidence we’ve always treated UTIs so I think it’s a number of different factors
that apply.” (GP 7)
The updated diagnostic tool:
• Clearly outlines the steps for clinical assessment of someone with
suspected UTI;
• Includes prompts/considerations around differential diagnosis,
pyelonephritis, and sepsis;
• References national sepsis guidance;
• References national guidelines on delayed and back-up
prescribing for UTIs;
• Clarifies criteria and risk factors for antibiotic resistance;
• References recent evidence; around hydration as a mechanism for
preventing recurrent UTI.
Most GP staff would not usually use a delayed/back-up prescription
for UTIs.
“Usually not so much UTIs because by then they’ve already had the symptoms
they’re coming in and they’re symptomatic, whereas a lot of people with sore
throats come in and say it started yesterday. So, you can give them delayed,
but I’m sure the percentage that cash in a delayed prescription is a lot higher” (GP
7)
Most groups reported that they would discuss antibiotic resistance
with some patients with an expected UTI, especially if there were
additional risk factors.
“Occasionally, gradually, particularly if they’ve got a recurrent UTI or if they’ve
had, say, side effects following antibiotics previously, like thrush. Then you might
have a conversation about the pros and cons.” (GP 3)
Hydration was discussed by most groups as a way to “flush out”
the bladder/infection and was seen by some as the reason that
cranberry juice is effective.
“Basically, just get as much fluid down you as you can and flush it out. Because
if the urine analysis is negative each time, . . . that’s all you can advise them.” (GP
6)
Beliefs about Capabilities
Though most practice staff used national guidance to manage UTIs,
some would not refer to it every time.
“I intermittently look at the guideline and make sure what I think and I’m doing
is correct, and then invariably I look and realise what I think I’m supposed to be
doing is slightly changed over the couple of months since I last read it.” (GP 2)
The updated diagnostic tool:
• Is developed to be integrated into GP systems so that it can be
updated and referred to easily.
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Table 3. Cont.
Domain and Findings * Quote (F Stands for Female, M for Male, Int Stands for Interviewer and GPStands for General Practice) How the Findings Influenced the UTI Diagnostic Tool
Memory, Attention, and Decision Making
Some GP staff believe that 3 day courses of antibiotics were not
sufficient. This was driven by patient expectations and perceived
efficacy of the dose and pressured them to lengthen the dose or use
a different antibiotic.
“M1: . . . I still find it quite hard to prescribe in three days, (some agreement)
because patients don’t like three days. M2: They don’t do they, they don’t think
it’s worth it . . . M3: They do not think that you’re giving them enough and that’s
quite tricky I think, I still find that, trying to convince them that three days will be
enough.” (GP 7)
“I never find that three days of antibiotic works. I get so many people coming back
(with UTI symptoms) that I don’t prescribe three days any more actually.” (GP 3)
The updated diagnostic tool:
• References national prescribing guidelines for UTIs which clearly
states risk factors and co-morbidities that need to be considered
when treating a UTI;
• References national guidelines on delayed and back-up
prescribing for UTIs;
• Clarifies criteria and risk factors for antibiotic resistance;
• Links to a UTI leaflet for women under 65 years that provides
support to a clinician when discussing with a patient:
o What a delayed prescription is and when to use it
o Risk related to antibiotic use and resistance.
Some GP staff would delay antibiotics when waiting for results from
urine culture if symptoms were mild.
“It depends on the day of the week, so if it’s a Thursday and the results aren’t
going to come back, I might give them a prescription and say let me send it, if you
get worse whilst you’re waiting for the results, that’s the context that I would do
that.” (GP 3)
Some GP staff would discuss completing the antibiotic course but were
less inclined to discuss antibiotic resistance in relationship to UTIs than
other infections, especially if they were confident in their diagnosis.
“I think it also depends on how convinced I am they’ve got a wee infection. So,
if I’m convinced they’ve got a wee infection, and they’re quite systemically unwell
with it, then I may not fight trying to give them the antibiotics as much as I might
do if they’re going: I’ve had a bit of dysuria and I don’t know quite what’s going
on.” (GP 4)
Various factors that would influence the clinician’s decision to provide
an immediate antibiotic include renal function; co-morbidity; diabetes;
immunosuppression; cost of treatment; pregnancy; severity of
symptoms; age of patient; and time before the weekend.
“EGFR, their diabetes status, the recurrence of the symptoms, whether they’re
pregnant or not, that sort of thing, so there’s quite a few other issues that I need to
then take on board despite the guidance that’s being given out.” (GP 8)
Optimism
One GP group was optimistic that the message about not receiving
an antibiotic immediately was becoming widely more accepted.
“People are starting to get that message now, with what’s been in the press, . . .
it’s refreshing that you now come across more patients who will say . . . I don’t
want one if I don’t have to have one. And if you say, let’s give this a few days or
let’s wait for the culture to come back or whatever and see, they’re OK with that.”
(GP 2)
The updated diagnostic tool:
• Links to a UTI leaflet for women under 65 years can be used by
a clinician when discussing with a patient about the need for
antibiotics and alternative options for UTI management.
Behavioural Regulation
The usefulness of a having an accurate point-of-care test was
mentioned by some groups, but the perceived benefit was often to
provide reassurance to the patient.
“ . . . oximetry, one thing I do with these people the ones who come with cold and
cough, I put them on the machine, I say look, oxygen, pulse is level, temperature
normal, you haven’t got an infection and they love it, so that reassures them.
If there was a something which we got, where we put the urine and say look,
it says there’s no infection. They will be happy.” (GP 6)
The updated diagnostic tool:
• Links to the TARGET Antibiotics Toolkit which provides tools to
audit UTI prescribing.
Some groups had audited their antibiotic prescribing recently and
none had audited antibiotic prescribing for UTIs specifically.
“Different members of staff have audited different topics, haven’t you? We’re
doing one at the moment . . . on COPD antibiotics. We have our own internal
audits and most of you do an audit for your appraisals and things as well don’t
you?” (GP 7)
Reinforcement
Most GP staff believed that patients expect to be prescribed
an antibiotic if they have urinary symptoms
“M1: I think, as *** has said, it’s patient expectations. F1: So they have these
symptoms and they’ve always had antibiotics. M1: They’ve had the symptoms.
F1: So they need antibiotics again, or they’ve got the same, the same symptoms
and don’t often consider that there might be another, another cause.” (GP 4)
The updated diagnostic tool:
• Links to a UTI leaflet for women under 65 years that provides
support to a clinician when discussing with a patient about:
o What a delayed prescription is and when to use it
o Risk related to antibiotic use.
There were no significant findings that were more related the domains of goals, intentions, and emotions than others covered above. * The terms used to attribute group consensus
in the results include “most”—4 or more focus groups agreed/discussed; or “some”—1 to 3 groups agreed/discussed.
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Data was triangulated through discussions during an expert stakeholder workshop discussed
previously (January 2018), where experts discussed and applied the findings to recommendations for
diagnostic tool development.
3. Consultations
3.1. Role and Professional Identity
Findings indicated that management of UTI in younger patients was shared by most staff
within the surgery. Receptionists in some surgeries asked patients who telephone with urinary
symptoms to bring urine samples into the surgery and provided guidance on sample collection. Nurses
often tested urine samples left by patients at reception and referred the patients to clinicians if they were
concerned the patient had a UTI. Nurse prescribers frequently managed patients with uncomplicated
cases of UTI, without any referral to other medical staff. GPs reported having face to face consultations
for UTIs and telephone consultations, managing complicated cases and treatment failure.
3.2. Role and Professional Identity/Environmental Context and Resources
Almost all focus groups reported that they may use telephone consultations to manage patients
who have a suspected UTI. At the telephone consultation, some clinicians asked for a urine sample to
be brought in but others considered this as unnecessary. Patients dropping unrequested urine samples
off at GP reception was reported by most groups as a challenge in diagnosing and managing UTIs,
and some groups reported that they would then have to ring the patient for a clinical history. Some
groups reported that they would prescribe antibiotics over the phone for a patient with 2–3 urinary
symptoms, only requesting clinical examination to rule out pyelonephritis if: the patient had recurrent
UTIs, there were any risk factors for more severe infection, or the clinician was worried about the patient.
3.3. Diagnosis
3.3.1. Skills
Three groups reported asking about vaginal discharge and considering other genitourinary causes
during a consultation for suspected UTI. Some of these groups indicated that other genitourinary
causes were considered later in the consultation after ruling out a UTI (by using urine dipstick).
There was a range of opinions on when to send a urine for culture and when to rely on urine
dipsticks for patients. Most groups said they would send a culture following treatment failure or for
a recurrent UTI. Some groups reported sending a urine for culture if the dipstick was negative but
the patient was symptomatic, if the patient was quite unwell, for male patients, for pregnant women,
and for children. Some groups indicated that they would not send a urine culture if the dipstick was
negative or if the symptoms clearly indicated an uncomplicated UTI.
3.3.2. Role and Professional Identity/Social Influence
Most groups indicated that urine would always be dipped if it was dropped at reception or brought
in with the patient who had a suspected UTI. Sometimes, this was at the request of the nurse/receptionist
and performed by the nurse. Some groups felt that patients expected that a dipstick would be used as
part of the diagnostic process. This expectation and readily available urine samples influenced their
decision to use urine dipsticks as part of the diagnostic process, though some prescribers indicated
that they would not ask for a sample if the patient was strongly symptomatic (with three symptoms,
as per the 2017 PHE UTI diagnostic guidance) [15]. Participants also reported varying interpretation
and use of urine dipsticks, especially when symptoms did not match the urine dipstick results.
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3.3.3. Environment Context and Resources
Most groups reported using the 2017 PHE UTI diagnostic guidance or local guidance to guide
decision making, though they might not refer to it every time [15] Participants reported that laboratory
specimen collection services were not frequent enough to allow culture results to inform treatment.
Some groups suggested that an accurate point-of-care test to aid in the diagnosis of a UTI would be
very useful. This was often related to the clinician’s desire to have a visible test with which to reassure
the patient, or a result to reliably determine the need for antibiotics.
3.3.4. Beliefs about Consequences/Environmental Context and Resources
Some groups indicated that concern that they might miss sepsis/pyelonephritis caused them to
be overly cautious when diagnosing and treating UTIs. When reviewing the ideas for the updated
diagnostic tool, most agreed that the exclusion of pyelonephritis and sepsis needed to be included,
as part of any updates. There was discussion about what stage pyelonephritis and sepsis should be
considered in a UTI consultation; some groups thought it should be excluded early on and others
thought it should be ruled out after UTI symptoms were discussed.
3.4. Medical Management
3.4.1. Environmental Context and Resources
Some groups expressed the need for more or clearer national guidance advising about key areas of
the management of UTIs. This included recurrent UTIs (three groups), catheterised patients (one group),
and frank haematuria (one group).
3.4.2. Reinforcement
Most groups expressed the belief that patients expect to be prescribed an antibiotic if they have
urinary symptoms, especially if they have had them before or if the dipstick is positive. This expectation
was reinforced by being given antibiotics at previous consultations for similar symptoms.
3.4.3. Memory, Attention, and Decision Making/Social Influence/Optimism
Most groups would not usually use a delayed/back-up prescription for UTIs. Some considered this
option when waiting for results from urine culture if symptoms were mild. Practices generally reported
that patients did not understand that a UTI can safely clear on its own and they expected antibiotics.
Some groups felt that patients more readily accepted why they might not be given an antibiotic right
away for a respiratory tract infection/flu because of the consistent messaging and campaigns in this
area, but these patients did not know that this message can also apply to UTI. One group was optimistic
that the message about not receiving an antibiotic immediately was becoming more widely accepted.
Various factors that would influence the clinician’s decision to provide an immediate antibiotic included
renal function, co-morbidity, diabetes, immunosuppression, cost of treatment, pregnancy, severity of
symptoms, age of patient, and duration of time before the weekend.
3.4.4. Beliefs about Consequences/Memory, Attention and Decision Making/Knowledge
Most groups reported that they would discuss antibiotic resistance with some patients with
a suspected UTI, especially if there were additional risk factors such as multiple courses of antibiotics.
Some GP staff would discuss the need to complete the antibiotic course with patients, but they were
less inclined to discuss antibiotic resistance in relationship to UTIs than other infections, especially
if they were confident in their diagnosis. When indicating risk factors for antibiotic resistance, practices
listed factors such as frequent/recent use of antibiotics, long duration or high doses of antibiotics,
recurrent UTI, and positive laboratory results.
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3.4.5. Social Influence/Memory, Attention and Decision Making
Three focus groups reported challenges associated with only prescribing a 3 day course of
antibiotics. Participants said these were often driven by patient expectations, since patients had
received longer courses in the past and felt that the shorter dose would not be as effective, even though
the cost is the same. Some prescribers also felt that the 3 day course was less effective than the longer
one, with many patients returning with symptoms. This pressured them to lengthen the dose or use
a different antibiotic.
3.4.6. Knowledge
Some groups reported that they did not know about or have the option of using pivmecillinam
or fosfomycin as second-line treatment for acute uncomplicated UTI and indicated this was because
laboratories did not provide antibiotic susceptibility testing for these antibiotics.
3.4.7. Behavioural Regulation
Some groups had audited their antibiotic prescribing, but none had audited antibiotic prescribing
for UTIs specifically.
3.5. Self-Care and Prevention
3.5.1. Skills/Knowledge
Most practices reported discussing self-management advice with their patients for mild symptoms
(especially with a negative dipstick) or for preventing UTI recurrence. Key themes for prevention
focused on hydration, cystitis sachets, cranberry products, lemon barley water, wiping front to back,
and sodium bicarbonate (one group). There was confusion regarding the evidence for effectiveness of
cystitis sachets and cranberry products for prevention or treatment of UTIs and whether these should
be recommended. Hydration was discussed by most groups as a way to “flush out” the bladder or
infection and was seen by some as the reason that cranberry juice is effective.
3.5.2. Social Influence/Environmental Context and Resources
Some focus groups reported that patients might have received cystitis sachets from the community
pharmacy and only came for a consultation if symptoms did not improve. Most groups indicated that
more information for patients was needed, including a UTI leaflet with a public health campaign that
covers the prevention and treatment of UTI, in line with national guidance.
4. Discussion
This study revealed practice and clinician variation in the use of urine dipsticks, empirical
antibiotic choice and course length, exclusion of genitourinary causes and pyelonephritis, use of
back-up/delayed antibiotics, and a lack of knowledge about the effectiveness of over-the-counter
products for the prevention and treatment of UTI. There was also variation in the use of pivmecillinam
and fosfomycin. Many UTIs were managed by nurse practitioners or by telephone consultation.
Our study found that clinicians reported using telephone consultations for the management
of UTI. Small studies evaluating the use of protocol-led telephone consultations to manage UTIs
show general success; however, a significant proportion of patients in these studies required physical
examination, referral, or the need for urine culture because of the risk of complications [25,26]. A recent
study in the United States of America (USA) assessed clinicians’ management of 20,600 telemedicine
patients who were diagnosed with a UTI [27]. The study did not provide any guidance for clinicians
regarding diagnosis and management of UTIs. Although the authors concluded that telemedical
management was generally successful, there was an increase in the use of quinolones (against the USA’s
national recommendations) in some groups and challenges with the management of patients with
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pyelonephritis, indicating that some clinicians would have benefited from simple decision-support
tools. These studies and guidance highlight that face to face consultations are optimal, but if this
is not possible there is a need to ensure that phone consultations follow an agreed diagnostic and
management practice protocol that helps exclude other causes of urinary symptoms such as vaginal
infection or atrophy, more severe infection like pyelonephritis, the initial signs of sepsis, and need
for urine culture. Remote consultations in England have increased during the COVID 19 pandemic
and digital-first primary care is part of the NHS Long-Term Plan [28,29]. Future diagnostic and
management tools need to include guidance that can be applied to various types of consultations,
including those done using phone or using other remote technology.
A recent UK study showed that overreliance on only urine dipsticks or clinical symptoms
only may contribute to an under diagnosis of UTI, due to the limited ability of both to rule out
infection [30]. Decision tools that use a combination of diagnostic symptoms and urine dipstick
results might improve diagnostic accuracy and are currently the most reliable and cost-effective tools
for the diagnosis of UTI [30–34]. However, clinicians need support to consider individual signs
and symptom and recommend treatment options such as delayed antibiotics. Although many of
the practice clinicians in our study followed national guidance to inform management, clinicians in our
study still perceive pressure from patients to use urine dipsticks and prescribe based on their results.
This patient expectation was perpetuated by ongoing use of urine dipsticks within the practice. Future
UTI diagnostic guidance should include guidance on the role and effectiveness of urine dipsticks
in detecting a UTI in all age groups, how dipstick results should be used alongside history and physical
examination, and tools for communicating information on the appropriate use of dipsticks across
the care pathway and with patients. UTI audits (that were not reported by any of our participants)
with feedback and action planning may help embed good practice into daily practice care [35,36].
Non-steroidal anti-inflammatory drugs for UTI when used without back-up antibiotic prescribing
for acute uncomplicated UTIs in women may lead to increased incidence of pyelonephritis [37].
However, NSAIDS used with the provision of a patient lead back-up antibiotic are acceptable to
patients, and reduce antibiotic use without increasing complications [30,38,39]. Current national
guidance includes recommendations for providing back-up antibiotics in women with uncomplicated
acute UTI along with appropriate pain relief and advice about hydration [40]. Our findings indicated
that GP staff felt that patients put pressure on clinicians to prescribe for a suspected UTI, and that this
is often driven by the dipstick result and previous management experiences. This perception is similar
to other qualitative research and could be related to lack of communication skills and knowledge
about the consequences of infection, symptom resolution and risks and benefits of NSAIDS versus
antibiotics [38,41]. Both patients and clinicians will need more information, evidence and discussion
about consequences of overuse of antibiotics versus back-up antibiotics to motivate them to use
back-up antibiotics more frequently for suspected UTI [38,41]. To improve public awareness, antibiotic
campaigns and patient-facing leaflets could use language more inclusive of non-respiratory infections
such as UTIs and highlight the benefits of back-up antibiotics. Continued effort should be put in to
development of a more accurate point-of-care test that can more accurately guide the need for and
choice of antibiotic [42].
Our findings, and others, show that at present, clinicians may not discuss non-pharmaceutical
self-care and prevention of UTIs with women during a consultation and that some women do try
over-the-counter products before seeking medical treatment [41]. National Institute for Health and Care
Excellence (NICE) guidance now includes information as to the effectiveness of non-pharmaceutical
products including cranberry, cystitis sachets and hydration for the prevention and management of
UTI for pharmacy and GP surgery staff [40]. The NICE evidence review found little robust research
to recommend cranberry products or other non-pharmaceutical means for the treatment of lower
UTI, but did find that some non-liquid cranberry products could be helpful in the prevention of
recurrent UTI for women under 65 [40,43]. A 2018 randomised control trial found that increasing water
intake over a year could help reduce the number and frequency of cystitis episodes experienced by
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pre-menopausal women with recurrent UTI who previously drank less than 1.5 L of fluid a day [44].
However, there is little other robust evidence to demonstrate the effect of hydration on UTIs. Given
the many non-pharmacological and non-antibiotic management options that are applied to all types
of UTI, further research is needed to support recommendations and timing for non-pharmaceutical
prevention of UTIs, hydration and “self-care” advice.
4.1. Other Studies
There are few qualitative studies assessing UTI management in primary care, with most focusing
on treatment options, prescribing and antibiotic resistance rather than diagnosis of UTI. Qualitative
data from an Irish study from 2015 highlighted the need for local antibiotic resistance surveillance data
to inform antibiotic choice [45]. This Irish study and another in England found that patients want to
discuss their illness and treatment options with their GP and are willing to accept a back-up/delayed
prescription if time has been taken to explain the rationale for it [38,45]. A UK-based study, using
qualitative data from GPs and female patients in 2011, showed that how a clinician manages a UTI
depends on a complex mix of factors. Internal factors include personality, knowledge, teaching,
and experience and external factors include perceived severity of diagnosis, guidance and protocols,
training, cost of treatment, and perceived patient expectations/feelings [41]. A 2013 Swedish study
indicated that GPs who most reliably follow treatment guidance for UTIs had a higher level of
awareness and concern about increasing antibiotic resistance than less compliant GPs [46].
4.2. Limitations and Strengths
This study used stratification and random sampling techniques to select participants, which will
have helped to limit bias. The sample size is also quite large when compared to other qualitative
studies, allowing for a wider range of stakeholders with varying views. By using a known behavioural
framework in the development of the focus group questions, we were able to ensure our interview
schedule covered key discussion topics needed to understand behaviours around UTI management.
This study was conducted alongside a programme of work to inform interventions to improve
management of UTIs. This included a UTI flowchart and leaflet for older adults, which could have
biased discussion to focus more on management in older adult patients, even when respondents were
asked to provide feedback specific to younger age/all groups. To limit this, we asked for information
about the general population or usual practice before prompting for information specific to older adults
in the interview schedule. It is noted that more GP surgery staff from Gloucestershire participated
in group discussions than from Nottingham (37 vs. 20, respectively). Gloucestershire CCG has almost
twice the population of Nottingham City CCG and the average surgery list size is about 1300 people
higher in Gloucestershire [47]. Because the strength of findings was based on consensus arising
from group discussions (not comments from individuals), this should have limited any bias towards
discussions with higher numbers of staff. Surgeries that were not able to participate indicated time
constraints (often related to lack of staff/illness or changes within the surgery) and “no research”
policies as a barrier to participation. This could have meant that our sample was biased towards
practices that were more knowledgeable and interested in research and clinical issues like antimicrobial
stewardship. However, topics related to antimicrobial stewardship were discussed at the end of
the general discussion so should not have biased the initial conversations about UTI management
in their practice. Further, there was a broad range of roles represented from across the practices,
and we did reach data saturation.
5. Conclusions
This study highlighted variation in the care pathway for managing UTIs in adult women. Findings
indicate this process could be improved by ensuring that guidance and protocols are appropriate
for face to face consultations, as well as those by phone or using other remote technology, providing
clear guidance on the effectiveness of urine dipsticks in detecting a UTI in all age groups. Practices
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should be encouraged to implement audits with feedback on UTI management. Tools to discuss
management decisions and antibiotics with patients should be available across the care pathway; public
campaigns around antimicrobial stewardship should use language more inclusive of non-respiratory
infections such as UTIs. Further high-quality research is needed to provide additional guidance around
non-pharmaceutical recommendations for “self-care” and prevention of UTIs.
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